Gaingels

Gaingels is a venture capital investment firm founded in 2014 and based in Burlington, Vermont. It specializes in investing in companies led by LGBT+ founders and C-suite leaders across various stages of growth, as well as in established firms aiming to create more inclusive teams. With a global portfolio of over 130 companies and $70 million in investment capital deployed, Gaingels actively supports its portfolio by helping to identify and recruit diverse talent for leadership roles. The firm fosters a vibrant community of industry leaders, investors, operators, and entrepreneurs who are united in their mission to drive positive social change through business and successful investments.

Past deals in Image Recognition

VerImmune

Seed Round in 2022
Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirects pre-existing pathogenic or childhood vaccine immune memory towards tumors.

Magnetic Insight

Series B in 2022
Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), a novel imaging modality that detects iron oxide nanoparticle tracers using time-varying magnetic fields. The company has developed several key products, including the MOMENTUM imager, a pre-clinical MPI solution that produces detailed images through advanced reconstruction techniques, and VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies. Additionally, the company offers Hyper, a module for localized magnetic hyperthermia, and Relax, which focuses on particle relaxometry. Founded in 2012 and based in Alameda, California, Magnetic Insight is dedicated to enhancing preclinical diagnostics and research by enabling quantitative cell tracking, imaging vascular functions, and detecting metastatic tumors, thereby addressing significant challenges in clinical and translational research.

Base64

Seed Round in 2022
Base64.ai is a startup focused on automating document processing using Generative AI and Large Language Models. It aims to transform the $100 billion Intelligent Document Processing market by offering the ability to understand various document types without requiring training. The platform can process over 2,800 document types, extracting information such as OCR text, data, handwriting, photos, and signatures. It verifies the extracted information and integrates it into customers' systems, significantly reducing manual data entry tasks and enhancing productivity. The company has filed four patent applications and boasts over 400 no-code integrations. As of recent reports, it has achieved a GAAP annual recurring revenue of $1.2 million, with a notable growth rate. Founded by Ozan Bilgen, who has a background in software engineering at major tech firms, Base64.ai secured $2 million in funding in 2022 from investors including Long Journey Ventures, Prime Zero, and Sequoia Scout.

Kneron

Series B in 2021
Kneron specializes in designing and developing integrated software and hardware solutions that enable artificial intelligence to function on devices at the edge. Their products serve a variety of applications, including smart homes, smart surveillance, smartphones, robots, drones, and IoT devices. Kneron offers AI System-on-Chips, visual recognition software development kits, and intellectual property for neural processing units.

Scopio

Venture Round in 2021
Scopio is an Online Community connecting photographers and visual artists to each other and to potential customers building the world's largest source of visual talent. Talented diverse artists from 190 countries have built profiles on Scopio, where they sell their images, tell their stories, and get hired for their visual art talent. Scopio powers its platform using AI to give access to anyone, anywhere to participate.

Nines

Series A in 2019
Nines is the first-of-its-kind teleradiology practice. Our radiologists and engineers are on a mission to build world-class tools in-house to enable the best radiologists to deliver the best patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.